Safety of antioxidant vitamins

Archives of Internal Medicine

Volumn 156, Issue 9, 1996, Pages 925-935

  Meyers, David G ^a   Maloley, Pierre A ^b,c   Weeks, David ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CREATININE; LIPOPROTEIN; RETINOL; THYROID HORMONE; TRIACYLGLYCEROL; VITAMIN;

ARTHRALGIA; BLOOD CLOTTING DISORDER; BONE PAIN; CLINICAL TRIAL; DRUG MEGADOSE; EMBRYOTOXICITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERVITAMINOSIS; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; NECROTIZING ENTEROCOLITIS; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINOL INTOXICATION; REVIEW; SEPSIS; SKIN TOXICITY; TERATOGENESIS;

ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CAROTENOIDS; HUMANS; VITAMIN A; VITAMIN E; VITAMINS;

EID: 0029942810     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.9.925     Document Type: Review

References (208)

1. Harris WS. The prevention of atherosclerosis with antioxidants. Clin Cardiol. 1992;15:636-640.
2. Meyers DG, Maloley PA. The antioxidant vitamins: impact on atherosclerosis. Pharmacotherapy. 1993;13:574-582.
3. Maxwell SRJ. Can anti-oxidants prevent ischaemic heart disease? J Clin Pharm Ther. 1993; 18:85-95.
4. Hennekens CH, Gaziano JM. Antioxidants and heart disease: epidemiology and clinical evidence. Clin Cardiol. 1993;16(suppl 1):1-10-1-15.
5. Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull. 1993;49:679-699.
6. Byers T, Perry G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Ann Rev Nutr. 1992;12:139-159.
7. Dorgan JF, Schatzkin A. Antioxidant micronutrients in cancer prevention. Hematol Oncol Clin North Am. 1991;5:43-68.
8. Willett WC, Hunter DJ. Vitamin A and cancers of the breast, large bowel, and prostate: epidemiologic evidence. Nutr Rev. 1994;52:553-559.
9. Prasad RN, Edwards-Prasad J. Vitamin E and cancer prevention: recent advances and future potentials. J Am Coll Nutr. 1992;11:487-500.
10. Block G. Vitamin C status and cancer: epidemiologic evidence of reduced risk. Ann N Y Acad Sci. 1992;669:280-290.
11. Delany L. The cardionutrients: vitamins that prevent heart ailments. Prevention. 1993;45:49-53.
12. Toufexis A. The new scoop on vitamins. Time. 1992;139:54-60.
13. Block G, Cox C, Madans J, Schreiber GB, Licitra L, Mella N. Vitamin supplement use, by demographic characteristics. Am J Epidemiol. 1988; 127:297-309.
14. Koplan JP, Annest JL, Layde PM, Rubin GL. Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health. 1986; 76:287-289.
15. Stewart ML, McDonald JT, Levy AS, Schucker RE, Henderson DP. Vitamin/mineral supplement use: a telephone survey of adults in the United States. J Am Diet Assoc. 1985;85:1585-1590.
16. Medeiros DM, Bock MA, Ortiz M, et al. Vitamin and mineral supplementation practices of adults in seven western states. J Am Diet Assoc. 1989;89:383-386.
17. Subas AF, Block G. Use of vitamin and mineral supplements: demographics and amounts of nutrients consumed: the 1987 health interview survey. Am J Epidemiol. 1990;132:1091-1101.
18. Steinburg D. Antioxidant vitamins and coronary heart disease. N Engl J Med. 1993;328: 1487-1489.
19. Hennekens CH, Eberleink. A randomized trial of aspirin and beta-carotene among US physicians. Prev Med. 1985;14:165-168.
20. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
21. Stampfer MJ, Hennekens CH, Mason JE. Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
22. Rimm EB, Stampfer MJ, Ascherio A, Gioviannucci E, Colditz GA, Willett WC. Vitamin consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
23. Olson JA. Adverse effects of large doses of vitamin A and retinoids. Semin Oncol. 1983;10: 290-293.
24. McCollum EV, Davis M. The necessity of certain lipids in the diet during growth. J Biol Chem. 1913;15:167-175.
25. Karner P, Helfenstein A, Wehrli H, Wettstein A. Pflanzenfabstoffe, XXV: über die Konstitution des Lycopins und Carotins. Helv Chim Acta. 1930;13:1084-1099.
26. Goodman DS. Vitamin A and retinoids in health and disease. N Engl J Med. 1984;310:1023-1031.
27. Mathus-Vliegen EMH, Tytgat GNJ. Biological fate of the vitamin A transporting protein complex and beta-carotene after excess dietary intake. Digestion. 1983;27:116-122.
28. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr. 1989;49:358-371.
29. Meyer KA, Popper H, Steigman F. Comparison of vitamin A of liver biopsy specimens with plasma vitamin A in man. Proc Soc Exp Biol Med. 1942;49:589-591.
30. Arroyeve G, Wilson D, Contreras C, Behar M. Alterations in serum concentrations of vitamin A associated with the hypoproteinemia of severe protein malnutrition. J Pediatr. 1963;62: 920-925.
31. Smith FR, Goodman DS. Vitamin A transport in human vitamin A toxicity. N Engl J Med. 1976; 294:805-808.
32. Weber FL, Mitchell GE, Powel DE, Reiser BJ, Banwell JG. Reversible hepatotoxicity associated with hepatic vitamin A accumulation in a protein deficient patient. Gastroenterology. 1982; 82:118-122.
33. Inkeles SB, Connor WE, Illingworth DR. Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Am J Med. 1986; 80:491-495.
34. Smith FR, Goodman DS, Zaklama MS, Gabr MK, Maraghy SE, Patwardhan VN. Serum vitamin A, retinol binding protein, and prealbumin concentration in protein-calorie malnutrition, I: a functional defect in hepatic retinol release. Am J Clin Nutr. 1973;26:973-981.
35. Smith FR, Goodman DS. The effects of disease of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest. 1971;50:2426-2436.
36. Kûrner WF, Völlm J. New aspects of the tolerance of retinol in humans. Int J Vit Nutr Res. 1975;45:363-368.
37. Lombaert A, Carton H. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents. Eur Neurol. 1976;14:340-350.
38. Rodahl K, Moore T. Vitamin A content and toxicity of bear and seal liver. Biochem J. 1943; 37:166-168.
39. Cleland JB, Southcott RV. Illnesses following the eating of seal liver in Australian waters. Med J Aust. 1969;1:760-763.
40. Bush ME, Dahms BB. Fatal hypervitaminosis A in a neonate. Arch Pathol Lab Med. 1984;108: 838-842.
41. Infante M, Pastorino U, Chiesa G, et al. Laboratory evaluation during high dose vitamin A administration: a randomized study of lung cancer patients after surgical resection. J Cancer Res Clin Oncol. 1991;117:156-162.
42. Stimson WH. Vitamin A intoxication in adults. N Engl J Med. 1961;265:369-373.
43. Fransisco A, Chakraborty J, Chowdhwy HR, et al. Acute toxicity of vitamin A given with vaccines in infancy. Lancet. 1993;342:526-527.
44. Lamantia RS, Andrews CE. Acute vitamin A intoxication. South Med J. 1981;74:1012-1014.
45. Furman KI. Acute hypervitaminosis A in an adult. Am J Clin Nutr. 1973;26:575-577.
46. Hathcock JN, Hatten DG, Jenkins NY. Evaluation of vitamin A toxicity. Am J Clin Nutr. 1990; 52:183-202.
47. Laplane R, Duche D, Jallut SM. Oedeme aigue cerebromeninge resolutif chez un garcon de 16 ans ayant absorbe une dose massive de vitamine A. Arch Fr Pediatr. 1953;10:979-982.
48. Marie J, See G. Acute hypervitaminosis A of the infant: its clinical manifestation and benign acute hydrocephaly and pronounced bulge of the fontanel: a clinical and biological study. AJDC. 1954;73:731-736.
49. Mikkelsen B, Ehlers N, Thomsen HG. Vitamin A intoxication causing papilloedema and simulating acute encephalitis. Acta Neurol Scand. 1974;50:642-650.
50. Morrice G, Havener WH, Kapetansky F. Vitamin A intoxication as a cause of pseudotumor cerebri. JAMA. 1960;173:1802-1805.
51. Reddy V, Mohonsam M. Effect of intramuscular vitamin A injection on plasma levels of vitamin A and retinol-binding protein in malnourished children. Br J Nutr. 1981;45:229-232.
52. Hatoff DE, Gentler SL, Miyai K, Parker BA, Weiss JB. Hypervitaminosis A unmasked by acute viral hepatitis. Gastroenterology. 1982;82:124-128.
53. Bauernteind JC. The Safe Use of Vitamin A: A Report of the International Vitamin A Consultative Group. Washington, DC: Nutrition Foundation; 1980.
54. Muenter MD, Perry HO, Judwig J. Chronic vitamin A intoxication in adults. Am J Med. 1971; 50:129-136.
55. Peck GL, Olsen TG, Yoder FW, et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med. 1979; 300:329-333.
56. Kligman AM, Mills OH, Leyden JJ, Gross PR, Allen HB, Rudolph RI. Oral vitamin A in acne vulgaris. Int Soc Trop Derm. 1981;20:278-285.
57. Band PR, Deschamps M, Falardeau M, Ladouceur J, Cote J. Treatment of benign breast disease with vitamin A. Prev Med. 1984;13:549-554.
58. Ragavan W, Smith JE, Bilezikian JP. Case report: vitamin A toxicity and hypercalcemia. Am J Med Sci. 1982;283:161-164.
59. Frame B, Jackson CE, Reynolds WA. Hypercalcemia and skeletal effects of chronic hypervitammosis A. Ann Intern Med. 1974;80:44-48.
60. Hofman KJ, Milne FJ, Schmidt C. Acne, hypervitaminosis A and hypercalcemia. S Afr Med J. 1978;54:579-580.
61. Pasquariello PS, Schut L, Borns P. Benign increased intracranial hypertension due to chroic vitamin A overdosage in a 26-month old child. Clin Pediatr. 1977;16:379-382.
62. Lowe NJ, David M. New retinoids for dermatologic diseases: uses and toxicity. Dermatol Clin. 1988;6:539-552.
63. Ayikama H, Nakamura N, Nagasaka S, Sakamaki H, Onozaway Y. Hypercalcaemia due to all-trans retinoic acid. Lancet. 1992;339:308-309.
64. Patel P, Hanning RM, Atkinson SA, Dent PB, Dolovich J. Intoxication from vitamin A in an asthmatic child. Can Med Assoc J. 1988;139: 755-756.
65. Farrington K, Miller P, Varghese Z, Baillod RA, Moorehead JF. Vitamin A toxicity and hypcalcaemia in chronic renal failure. BMJ. 1981;282: 1999-2002.
66. Miller P, Sweny P, Persaud JW, et al. The effects of vitamin A toxicity on calcium and lipid metabolism in chronic renal failure. Proc EDTA. 1981;18:573-578.
67. Wolbach SB. Vitamin A deficiency and excess in relation to skeletal growth J Bone Joint Surg. 1947;29:171-192.
68. Jowsey J, Riggs BL. Bone changes in a patient with hypervitaminosis A. J Clin Endocrinol Metab. 1968;28:1833-1835.
69. Bergman SM, Mailia JO, Krane NK, Wallin JD. Vitamin-A-induced hypercalcemia: response to corticosteroids. Nephron. 1988;50:362-364.
70. Guarascio P, Portmann B, Visco G, Williams R. Liver damage with reversible portal hypertension from vitamin A intoxication: demonstration of Ito cells. J Clin Pathol. 1983;36:769-771.
71. Geubel AP, deGaloscy C, Alves N, Rahier J, Dive C. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology. 1991; 100:1701-1709.
72. Farrell GC, Bhathal PS, Powell LW. Abnormal liver function in chronic hypervitaminosis A. Dig Dis. 1977;22:724-728.
73. Smith JW. Vitamin A toxicity presenting as jaundice. Postgrad Med. 1989;85:53-56.
74. Bioulac-Sage P, Quinton A, Saric J, Grimaud BA, Mourey MS, Balabaud C. Chance discovery of hepatic fibrosis in patient with asymptomatic hypervitaminosis A. Arch Pathol Lab Med. 1988;112:505-509.
75. Sarles J, Schemer C, Sarran M, Giraud F. Hepatic hypervitaminosis A: a familial observation. J Pediatr Gastroenterol Nutr. 1990;10:71-75.
76. Mendoza FS, Johnson F, Kerner JA, Tune BM, Shochat SJ. Vitamin A intoxication presenting with acites and a normal vitamin A level. West J Med. 1988;148:88-90.
77. Rosenberg HK, Berezin S, Heyman S, Witzleben C, Watkins JB. Pleural effusion and ascites. Clin Pediatr. 1982;21:435-440.
78. Minuk GY, Kelly JK, Hwang WS. Vitamin A hepatoxicity in multiple family members. Hepatology. 1988;8:272-275.
79. Kent G, Inouye T, Bahu R, Minick DT, Popper H. Vitamin A containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci USA. 1976;73:3719-3722.
80. Eaton ML. Chronic hypervitaminosis A. Am J Hosp Pharm. 1978;35:1099-1102.
81. Jagnes EA, Buschmann RJ, Jayden TJ. The histologic progression of vitamin A-induced hepatic injury. Gastroenterology. 1979;76:599-602.
82. Babb RB, Kieraldo JH. Cirrhosis due to hypervitaminosis A. West J Med. 1978;128:244-246.
83. Fleischman R, Schlote W, Schomerus H, Wolburg H, Castrillon-Oberndoffer WL, Hoensch H. Kleinknotige Leberzirrhosemit ausgeprägter portaler hypertension als folge einer vitamin-A intoxikation bei psoriasis behandlung. Dtsch Med Wochenschr. 1977;102:1637-1640.
84. Shmunes E. Hypervitaminosis A in a patient with alopecia receiving renal dialysis. Arch Dermatol. 1979;115:882-883.
85. Lieber CS. Interaction of alcohol with other drugs and nutrients. Drugs. 1990;40:23-44.
86. Rubin E, Florman AL, Degnan T, Diay J. Hepatic injury in chronic hypervitaminosis A. AJDC. 1970;119:132-138.
87. Kistler HJ, Pluer S, Dickenmann W, Pirozynski W. Portale hypertonie ohne leberzimhose bei chronischer vitamin-A-intoxikation. Schweiz Med Wochenschr. 1977;107:825-832.
88. Walters BNJ, Gabbay SS. Tetracycline and benign intracranial hypertension: report of five cases. BMJ. 1981;282:19-20.
89. Moskowitz Y, Leibowitz E, Ronen M, Aviel E. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol. 1993; 25:306-308.
90. DiBenedetto RJ. Chronic hypervitaminosis in an adult. JAMA 1967;201700-702.
91. Restak RM. Pseudotumor cerebri psychosis and hypervitaminosis A. J Nerv Ment Dis. 1972; 155:72-75.
92. Marsden JR. Lipid metabolism and retinoid therapy. Pharmacol Ther. 1989;40:55-65.
93. Stansfield SK, Pierre-Lowis M, Lerebows G, Augustin A. Vitamin A supplementation and increased prevalence of childhood diarrhea and acute respiratory infections. Lancet. 1993;342: 578-582.
94. Bandrinath P, Chakladar BK, Rao TSK. Effect of massive doses of vitamin A on morbidity and mortality in Indian children. Lancet. 1991;29: 849-850.
95. Kartasasmita CB, Rosmayudi O, Soemantir ES, Deville W, Denedts M. Vitamin A and acute respiratory infections. Paediatr Indones. 1991;31: 41-49.
96. Muntaner P, Rodriguez C, Arnau JM. Fever associated with chronic retmol therapy. Lancet. 1990;335:1588-1589.
97. Kizer KW, Fan AM, Bankowska J, Jackson RJ, Lyman DO. Vitamin A: a pregnancy hazard alert. West J Med. 1990;152:78-81.
98. Shenefelt RE. Morphogenesis of malformations in hamsters caused by retinoic acid: relation to dose and stage at treatment. Teratology. 1971;5:103-118.
99. Teratology Society. Teratology Society position paper: recommendations for vitamin A use during pregnancy. Teratology. 1987;35:269-275.
100. Gorodischer R. Micronutrients and drug response: vitamin A and vitamin E in the fetus and in the newborn. Dev Pharmacol Ther. 1990; 15:166-172.
101. Rothman KJ, Moore LL, Singer MR, Nguyen UDT, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. In press.
102. US Bureau of the Census. Statistical Abstract of the United States: 1993. 113th ed. Washington, DC: US Bureau of the Census; 1993: 15.
103. Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy in patients with Crohn's disease. Gastroenterology. 1985;88:512-514.
104. Landman J, Sive A, DeVheese H, VanDerElst C, Sacks R. Comparison of enterai and intramuscular vitamin A supplementation in preterm infants. Early Hum Dev. 1992;30:163-170.
105. Peck GL, Yoder FW. Treatment of lamellar ichthyosis and other keratinising dermatoses with an oral synthetic retinoid. Lancet. 1976;321: 1172-1174.
106. Goodman DS. Overview of current knowledge of metabolism of vitamin A and carotenoids. J Natl Cancer Inst. 1984;73:1375-1379.
107. Rock GA, Decary F, Cole RS. Orange plasma from tanning capsules. Lancet. 1981;330:1419-1420.
108. Bendich A. The safety of β-carotene. Nutr Cancer. 1988;11:207-214.
109. Kobza A, Ramsay CA, Magnus IA. Oral beta-carotene therapy in actinic reticuloid and solar urticaria. Br J Dermatol. 1973;88:157-166.
110. Underwood BA. Vitamin A intoxication. JAMA. 1985;254:301.
111. Shute WE, Taub HJ, eds. Vitamin E for Ailing and Healthy Hearts. New York, NY: Pyramid Books; 1972:7-207.
112. Bieri JG, Corash L, Hubbard VS. Medical uses of vitamin E. N Engl J Med. 1983;308:1063-1071.
113. Cohn VH. Fat-soluble vitamins, III: vitamin A and vitamin E. In: Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 4th ed. London, England: Macmillan Co; 1970: 1690-1699.
114. Committee on Dietary Allowances, Food and Nutrition Board, National Research Council. Recommended Dietary Allowances. 9th ed. Washington, DC: National Academy Press; 1980.
115. Machlin LJ. Vitamin E. In: Machlin U, ed. Handbook of Vitamins: Nutritional, Biochemical, and Clinical Aspects. New York, NY: Marcel Dekker Inc; 1984:100-145.
116. Federation of American Societies for Experimental Biology. Evaulation of the Health Aspects of Tocopherols and α-Tocopheryl Acetate as Food Ingredients. Washington, DC: Federation of American Societies for Experimental Biology; 1975.
117. Bell EF. Upper limit of vitamin E in infant formulas. Pediatr Nutr. 1989;51:1829-1831.
118. Sokol RJ, Heubi JE, Butler-Simon N, McClung HJ, Lilly JR, Silverman A. Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-α-tocopheryl polyethyleglycol-1000 succinate. Gastroenterology. 1987; 93:975-985.
119. Farrell PM, Bieri JC. Megavitamin E supplementation in man. Am J Clin Nutr. 1975;18: 1381-1386.
120. Dymsza HA, Park J. Excess dietary vitamin E in rats. Fed Proc. 1975;34:912.
121. Stampfer MJ, Willett W, Castelli WP, Taylor JO, Fine J, Hennekens CH. Effect of vitamin E on lipids. Am J Clin Pathol. 1983;79:714-716.
122. Gillilan RE, Mondell B, Warbasse JR. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J. 1977;93:444-449.
123. Bierenbaum ML, Noonan FJ, Machlin LJ, et al. The effect of supplemental vitamin E on serum parameters in diabetics, post-coronary, and normal subjects. Nutr Rep Int. 1985;31:1171-1180.
124. Salkeld RM. Safety and tolerance of high-dose vitamin E administration in man: a review of the literature. Fed Reg. 1979;44:16172.
125. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr. 1988;48:612-619.
126. Centers for Disease Control. Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product. MMWR Morb Mortal Wkly Rep. 1984;33:198-199.
127. Bove KE, Kosmetatos N, Wedig KE, et al. Vasculopathic hepatotoxicity associatied with E-Ferol syndrome in low birth weight infants. JAMA. 1985;254:2422-2430.
128. Arrowsmith JB, Faich GA, Tomita DK, Kwitsky JN, Rosa RW. Morbidity and mortality among low birth weight infants exposed to an intravenous vitamin E product, E-Ferol. Pediatrics. 1989;83:244-249.
129. Hittner HM, Godio LB, Rudolph AJ, et al. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med. 1981;305:1365-1371.
130. Finer NN, Peters KL, Hayek Z, Merkel CL Vitamin E and necrotizing enterocolitis. Pediatrics. 1984;73:387-393.
131. Johnson L, Bowen FW, Abbasi S, et al. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics. 1985; 75:619-638.
132. Phelps DL, Rosenbaum AL, Isenberg SL, Keake RD, Dorey FJ. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial. Pediatrics. 1987;79:489-500.
133. Baehner R, Boxer L, Allen J, et al. Autooxidation as a basis for altered function by polymorpnonuclear leukocytes. Blood. 1977;50:327-335.
134. Prasad J. Effect of vitamin E supplementation on leukocyte function. Am J Clin Nutr. 1980; 33:606-608.
135. Harman D, Heidrick ML, Eddy DE. Free radical theory of aging: effect of free-radical-reaction inhibitors on immune response. J Am Geriatr Soc. 1977;25:400-407.
136. Corrigan J, Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA. 1974;230: 1300-1301.
137. March BE, Wong E, Seier L, Sim L, Biely J. Hypervitaminosis E in the chicks. J Nutr. 1973; 103:371-377.
138. Olson RE, Jone JP. The inhibition of vitamin K action by D-α-tocopherol and its derivatives. Fed Proc. 1979;38:2542.
139. Corrigan JJ, Ulfers LL. Effect of vitamin E on prothrombin levels of warfarin-induced vitamin K deficiency. Am J Clin Nutr. 1981;34: 1701-1705.
140. Woolley DW. Some biological effects produced by α-tocopherolquinone on vitamin K dependent carboxylation. Fed Proc. 1982;41: 344.
141. Bettger WJ, Olson RE. Effect of α-tocopherol and α-tocopherolquinone on vitamin K-dependent carboxylation. Fed Proc. 1982;41: 344.
142. Vitamin K, vitamin E and the coumarin drugs. Nutr Rev. 1982;40:180-181.
143. Roberts HJ. Perspective on vitamin E as therapy. JAMA. 1981;246:129-131.
144. Fitzgerald GA, Brash AR. Endogenous prostacyclin and thromboxane biosynthesis during chronic vitamin E therapy in men. Ann N Y Acad Sci. 1982;393:209-211.
145. Cohen HM. Fatigue caused by vitamin E. N Engl J Med. 1973;281:980.
146. Briggs M. Vitamin E supplements and fatigue. N Engl J Med. 1974;290:579-580.
147. Kligman AM. Vitamin E toxicity. Arch Dermatol. 1982;118:289.
148. Ayres S, Mihan R. Vitamin E supplements and fatigue. N Engl J Med. 1974;290:580.
149. Tsai AC, Kelley JJ, Peng B, Cook N. Study on the effect of megavitamin E supplementation in man. Am J Clin Nutr. 1978;31:831-837.
150. Hillman RW. Tocopherol excess in man: creatinuria associated with prolonged ingestion. Am J Clin Nutr. 1957;5:597-600.
151. Roberts HJ. Vitamin E and thrombophlebitis. Lancet. 1978;325:49.
152. Sundaram GS, London R, Manimekalai S, et al. Effects of α-tocopherol therapy on serum lipoprotein cholesterol levels in mammary dysplasia. Clin Chem. 1980;26:1025-1026.
153. Gonzalez ER. Vitamin E relieves most cystic breast disease: may alter lipids, hormones. JAMA. 1980;244:1077-1078.
154. SatoY. Study of developmental pharmacology of vitamin E, part 2: experimental study on the nutrition of rats administered vitamin E. Folia Pharmacol. 1973;69:379-381.
155. Czyba JC, Girod C, Durand N. Modifications morphologiques de la thyroide du hamster dore traite par la vitamine E. R Soc Biol. 1966;160:2101.
156. Welch AL. Lupus erythematosus: treatment by combined use of massive amounts of pantothenic acid and vitamin E. Arch Dermatol Syphi-lol. 1954;70:181-198.
157. Anderson TW, Reid DBW. A double-blind trial of vitamin E in angina pectoris. Am J Clin Nutr. 1974;27:1174-1178.
158. Lemons JA, Maisels MJ. Vitamin E: how much is too much. Pediatrics. 1985;76:625-627.
159. Herbert VD. Megavitamin therapy. J Am Pharm Assoc. 1977;17:764-766.
160. Gershoff SN. Vitamin C (ascorbic acid): new roles, new requirements. Nutr Rev. 1993:51: 313-326.
161. Stewart ML, McDonald JT, Levy AS, Schucker RE, Henderson DP. Use of vitamin C. J Am Diet Assoc. 1985;85:1585-1590.
162. Rivers JM. Safety of high-level vitamin C ingestion. Ann N Y Acad Sci. 1987;498:445-454.
163. Berger L, Gerson CD, Yu T. The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. Am J Med. 1977;62:71-76.
164. Hagler L, Herman RH. Oxalate metabolism, II: urinary oxalate and the diet. Am J Clin Nutr. 1973;26:758-765, 882-889.
165. Sestili MA. Possible adverse health effects of vitamin C and ascorbic acid. Semin Oncol. 1983; 10:299-304.
166. Harris AB. Vitamin C-induced hyperoxaluria. Lancet. 1976;321:366.
167. McMichael AJ. Kidney stone hospitalization in relation to changes in vitamin C consumption in Australia 1966-1976. Community Health Stud. 1978;2:9-13.
168. Roth DA. Vitamin C and oxalate stones. JAMA. 1977;237:2080.
169. Friedman AL, Chesney RW, Gilchrist KW, Latorraca R, Segar WE. Secondary oxalosis as a complication of parenteral alimentation in acute renal failure. Am J Nephrol. 1983;3:248-252.
170. McAllister CJ. Renal failure secondary to massive infusion of vitamin C. JAMA. 1984;252: 1684.
171. Balcke P, Schmidt P, Zazgornik J, Kopsa H, Haubenstock A. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis. Ann Intern Med. 1984;101:344-345.
172. Swartz RD, Wesley JR, Somermeyer MG, Lau K. Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. Ann Intern Med. 1984;100: 530-531.
173. Stein HB, Hasan A, Fox IH. Ascorbic acid-induced uricosuria. Ann Intern Med. 1976;84: 385-388.
174. Brown RG. Possible problems of large intakes of ascorbic acid. JAMA. 1973;224:1529-1530.
175. Thorton PA. Influence of exogenous ascorbic acid on calcium and phosphorus metabolism in the chick. J Nutr. 1970;100:1479-1486.
176. Brown RG, Sharma VD, Young LG. Connective tissue metabolism in swine, II: influence of energy level and ascorbate supplementation on hydroxyproline excretion. Can J Anim Sci. 1971; 51:439-443.
177. Hallberg L. Effect of vitamin C on the bioavailability of iron from food. In: Counsell JN, Hornig DH, eds. Vitamin C (Ascorbic Acid). Princeton, NJ: Applied Science Publishers; 1981:49.
178. Cook JD, Watson SS, Simpson KM, Lipschitz DA, Skikne BS. The effect of high ascorbic acid supplementation on body iron stores. Blood. 1984;64:721-724.
179. Malone HE, Kevany JP, Scott JM, O'Broin SD, O'Connor G. Ascorbic acid supplementation: its effects on body iron stores and white blood cells. Ir J Med Sci. 1986;155:74-79.
180. Bendich A, Cohen M. Ascorbic acid safety: analysis of factors affecting iron absorption. Toxicol Lett. 1990;51:189-201.
181. O'Brien RT. Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in the thalassemia major. Ann N Y Acad Sci. 1974; 232:221-225.
182. Campbell GD, Steinberg MH, Bower JD. Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med. 1975;82:810.
183. Shilotri PG, Bhat KS. Effect of megadoses of vitamin C on bactericidal activity of leukocytes. Am J Clin Nutr. 1977;30:1077-1081.
184. 12 by ascorbic acid. JAMA. 1974;230:241-242.
185. Hurrobin DF. DVT after vitamin C? Lancet. 1973; 315:317.
186. Rosenthall G. Interaction of ascorbic acid and warfarin. JAMA. 1971;215:1671.
187. Smith EC, Skalski RJ, Johnson GC, Rossi GV. Interaction of ascorbic acid and warfarin. JAMA. 1972;221:1166.
188. Hume R, Johnston JMS, Weyers E. Interactions of ascorbic acid and warfarin. JAMA 1972; 219:1479.
189. Meyers FH, Jawetz E, Goldfien A. Review of Medical Pharmacology. 6th ed. Los Altos, Calif: Lange Medical Publication; 1972:444.
190. Milne MD. Influence of acid-base balance on efficacy and toxicity of drugs. Proc R Soc Med. 1965;58:961-963.
191. Morris JC, Beelay L, Ballantine N. Interaction of ethinyl estradiol with ascorbic acid in man. BMJ. 1981;283:503.
192. Furlanut M, Montanari G, Rusca F. Possible interaction between aminophylline and ascorbic acid. Br J Clin Pharmacol. 1985;19:528-529.
193. Walta DC, Giddens JD, Johnson LF, Kelley JL, Waugh DF. Localized proximal esophagitis secondary to ascorbic acid ingestion and esophageal motility disorder. Gastroenterology. 1976; 70:766-769.
194. Pauling L; Williams RJ, Kalita DK, eds. A Physician's Handbook on Orthomolecular Medicine. Hartford, Conn: Keats Publishing Inc; 1977: 45-50.
195. Hoyt CJ. Diarrhea from vitamin C. JAMA. 1980; 244:1674.
196. Bail L, Callaway E. Vitamin C and migraine: a case report. N Engl J Med. 1978;299:364.
197. Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975;83:824-826.
198. Christian DG. Drug interference with laboratory blood chemistry determinations. Am J Clin Pathol. 1970;54:118-142.
199. Singh MP, Hebert MA, Gault MH. Effect of some drugs on clinical laboratory values as determined by the Technicon SMA 12/60. Clin Chem. 1972;18:137-144.
200. VanSteirteghem AC, Robertson EA, Young DS. Influence of large doses of ascorbic acid on laboratory test results. Clin Chem. 1978;24:54-57.
201. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973;43:305-310.
202. Young DS, Thomas DW, Friedman RB, Pestaner LC. Effects of drugs on clinical laboratory tests. Clin Chem. 1972;18:1041-1073.
203. Buttery JE, Boord S, Ludvigsen N. Ascorbate interference in the urinary screen for acetaminophen. Clin Chem. 1988;34:769.
204. Stitch HF, Karim J, Koropatnick J, Lo L. Mutagenic action of ascorbic acid. Nature. 1976; 260:722-724.
205. Omura H, Shinohara K, Maeda H, Nomaka M, Murakami H. Mutagenic action of triose reductone and ascorbic acid on Salmonella typhimurium TA 100 strain. J Nutr Sci Vit. 1978; 24:185-194.
206. Norkus EP, Kuenzig W, Conney AH. Studies on the mutagenic activity of ascorbic acid in vitro and in vivo. Mutat Res. 1983;117:183-191.
207. Engstrom JE, Pauling L. Mortality among health-conscious elderly Californians. Proc Natl Acad Sci U S A. 1982;79:6023-6027.
208. Engstrom JE, Kanin LE, Breslow L. The relationship between vitamin C intake, general health practice, and mortality in Alameda County, California. Am J Public Health. 1986;76:1124-1130.